Dr. Dinglasan recently received a $1.3 million grant to bring a prototype rapid-diagnostic test for malaria to commercial viability. The test uses saliva, which eliminates the dependence upon blood of all other current tests; and it is able to detect “subclinical” infections — in other words, it can diagnose malaria even before someone feels really sick. Getting subclinical infections treated is key to eliminating malaria because these infections form a reservoir that fuels transmission back into mosquitoes when they take a blood meal –  (Source: http://www.positivelyfilipino.com/in-brief)


Congratulations, Dr. Rhoel David R. Dinglasan, a University of Florida professor and LSGH alumnus, Batch ’89, and his team of researchers, for winning a prestigious award from the National Institute of Health’s Technology Accelerator Challenge for the CLIP-CAM, a rapid, smartphone adapter that allows the user to submit a saliva sample for detection of COVID-19 and other blood-borne diseases such as malaria and anemia.  

 “The idea is, more people can now use an app on your iPhone, with our adapter, with our test, and basically get tested within half an hour from the comfort of their own home,” said Dinglasan.

Dinglasan’s team placed 2nd in the competition, receiving $200,000 which they intend to use for prototype development and, eventually, production for public use.  

Animo La Salle!